CAMBRIDGE, Mass., Oct. 27 /PRNewswire-FirstCall/ -- Idenix
Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that the
Company will hold an Analyst Day event during the upcoming 61st
Annual Meeting of the American Association for the Study of Liver
Diseases (AASLD) on Saturday, October 30,
2010 from 9:00 a.m. to 12:00 p.m.
ET at the Mandarin Oriental, Boston.
The live and archived webcast of the presentation can be
accessed under "Calendar of Events" in the Idenix Investor Center
at www.idenix.com. Please log in approximately 5-10 minutes
before the event to ensure a timely connection. The archived
replays will be available on the Idenix website for two weeks
following the event.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a
biopharmaceutical company engaged in the discovery and development
of drugs for the treatment of human viral diseases. Idenix's
current focus is on the treatment of infections caused by the
hepatitis C virus. For further information about Idenix, please
refer to http://www.idenix.com.
Idenix Pharmaceuticals'
Contacts:
|
|
Jonae Barnes (617) 224-4485
(investors)
|
|
Kelly Barry (617) 995-9033
(media)
|
|
|
SOURCE Idenix Pharmaceuticals, Inc.
Copyright . 27 PR Newswire